ADQ completed the acquisition of Amoun Pharmaceutical Company from Bausch Health for $740m.

ADQ, one of the UAE's largest holding companies, completed the acquisition of Amoun Pharmaceutical Company, a pharmaceutical manufacturer, from Bausch Health, a multinational specialty pharmaceutical company, for $740m. "The sale of Amoun marks significant progress in our efforts to reduce overall Bausch Health debt as we continue to pursue all opportunities to drive value for our shareholders, including preparing for the spinoff of Bausch + Lomb," Joseph C. Papa, Bausch Health Chairman and CEO.